---
title: Development of the treatment preference in myelodysplasia questionnaire for
  clinicians, carers, and patients
date: '2024-06-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38895084/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240619181657&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: This study reports the development activities for the Treatment Preference
  Myelodysplasia Questionnaires (TPMQ) for clinicians (mTPMQ), carers (cTPMQ), and
  patients (pTPMQ). These tools are intended to evaluate treatment preferences for
  patients with myelodysplastic syndromes (MDS). This was a non-interventional, cross-sectional
  qualitative interview study consisting of interviews with clinicians, patients,
  and those caring for patients with MDS. All participants were located in Australia
  ...
disable_comments: true
---
This study reports the development activities for the Treatment Preference Myelodysplasia Questionnaires (TPMQ) for clinicians (mTPMQ), carers (cTPMQ), and patients (pTPMQ). These tools are intended to evaluate treatment preferences for patients with myelodysplastic syndromes (MDS). This was a non-interventional, cross-sectional qualitative interview study consisting of interviews with clinicians, patients, and those caring for patients with MDS. All participants were located in Australia ...